Skip to main content
PLOS One logoLink to PLOS One
. 2024 Jan 31;19(1):e0298250. doi: 10.1371/journal.pone.0298250

Correction: Global adoption of 6-month drug-resistant TB regimens: Projected uptake by 2026

The PLOS ONE Staff
PMCID: PMC10830013  PMID: 38295059

Notice of Republication

This article was republished on January 22, 2024, to correct error in the data availability statement: Personal email addresses of multiple personnel were erroneously provided in the data availability statement. An incorrect version of the S1 File was also published in error. The publisher apologises for these errors. Please download this article again to view the correct version.

Reference

  • 1.Gupta A, Juneja S, Babawale V, Rustam Majidovich N, Ndjeka N, Thi Mai Nguyen P, et al. (2024) Global adoption of 6-month drug-resistant TB regimens: Projected uptake by 2026. PLoS ONE 19(1): e0296448. 10.1371/journal.pone.0296448 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLOS ONE are provided here courtesy of PLOS

RESOURCES